IRCT20160530028182N6已完成3 期
The effect of betahistine on hyperactivity disorder in children
Sanandaj University of Medical Sciences0 个研究点目标入组 76 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 76
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 8 years 至 18 years（—）
- 性别
- All
入选标准
- •Age between 8-18 years
- •Diagnosis of ADHD and ODD based on DSM5 without effective medication
- •Taking on mental status at least 2 weeks before the study
排除标准
- •Intelectual disability based on clinical suspicious
- •Presence of uncontroled siezure
- •Drug side effects and hypersensivity
- •Recieving of any other drugs
- •History of psychological disorder except for ADHD and ODD
- •Presence of medical diseases such as cardiac diseases
研究者
相似试验
已完成
1 期
Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity DisorderAttention Deficit Disorder With HyperactivityNCT00829881P2D, Inc.16
已完成
不适用
Biphentin Effects in attention deficit hyperactivity disorder (ADHD) DriversISRCTN77828247Purdue Pharma (Canada)30
已完成
不适用
Efficacy of high dosage of betahistine in patients with unilateral peripheral vestibulopathyunilateral peripheral vestibulopathyJPRN-UMIN000017711niversity of Tokushima225
尚未招募
3 期
Betahistine and Weight- Related and Metabolic Measures in schizophrenic Patients Treated with Olanzapin or RisperidoneSchizophreniaIRCT20191223045870N1Mashhad University of Medical Sciences56
进行中（未招募）
不适用
The effect of betahistine 48 mg three times daily on motion sickness - betahistineEUCTR2008-000885-21-NLTNO